Evidence map›Paper›PMID 35760390›Full record

ArticleThe Journal of allergy and clinical immunology2022

Human IgE mAbs identify major antigens of parasitic worm infection.

Azadeh Hadadianpour, Jacob Daniel, Jian Zhang, Benjamin W Spiller, Asta Makaraviciute, Åsa M DeWitt, Heather S Walden, Robert G Hamilton, R Stokes Peebles, Thomas B Nutman and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Current research in parasitology & vector-borne diseases · 2025
    Article
  7. Article
  8. Engineering therapeutic monoclonal antibodies.The Journal of allergy and clinical immunology · 2024
    Review
  9. Review
  10. Feast for thought: A comprehensive review of food allergy 2021-2023.The Journal of allergy and clinical immunology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Azadeh HadadianpourDepartments of Medicine and Pathology, Nashville, Tenn; departments of Medicine Microbiology and Immunology, Nashville, Tenn.
Jacob DanielDepartments of Medicine and Pathology, Nashville, Tenn; departments of Medicine Microbiology and Immunology, Nashville, Tenn.
Jian ZhangDepartments of Medicine and Pathology, Nashville, Tenn; departments of Medicine Microbiology and Immunology, Nashville, Tenn.
Benjamin W Spillerdepartments of Medicine Microbiology and Immunology, Nashville, Tenn; Pharmacology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tenn.
Asta MakaraviciuteSpecial Allergen Service, Thermo Fisher Scientific, Uppsala, Sweden.
Åsa M DeWittSpecial Allergen Service, Thermo Fisher Scientific, Uppsala, Sweden.
Heather S WaldenDepartment of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, Fla.
Robert G HamiltonDermatology, Allergy and Clinical Immunology Laboratory, Johns Hopkins University School of Medicine, Baltimore, Md.
R Stokes PeeblesDepartments of Medicine and Pathology, Nashville, Tenn; departments of Medicine Microbiology and Immunology, Nashville, Tenn.
Thomas B NutmanLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Scott A SmithDepartments of Medicine and Pathology, Nashville, Tenn; departments of Medicine Microbiology and Immunology, Nashville, Tenn. Electronic address: scott.smith.1@vumc.org.
Tenneco (United States) · USThermo Fisher Scientific (Sweden) · SEJohns Hopkins University · USNational Institutes of Health · USUniversity of Florida · USVanderbilt University Medical Center · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Dawn C Newcomb · 2011 to 2026
$34.9M
Th2-associated responses and their control in parasitic helminth infections and related disordersZIAAI000805 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2024
$4.4M
Comprehensive antigenic mapping of the human anti-peanut IgE antibody responseR01AI155668 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2021 to 2025
$4.1M
PGI2 augments Treg functionR01AI145265 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEBLES, RAY STOKES · 2019 to 2023
$2.7M
GLP-1R signaling in allergic inflammationR01AI124456 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NISWENDER, KEVIN D, PEEBLES, RAY STOKES · 2017 to 2021
$2.2M
Antigenic landscape of the human helminth IgE antibody responseR01AI130459 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2017 to 2021
$1.8M
Key determinants of dengue virus neutralization by naturally occurring human mAbsK08AI103038 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2012 to 2016
$631k
Host genetics of allergen-induced lung TSLP expression and ILC2 functionR21AI145397 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEBLES, RAY STOKES · 2019 to 2020
$468k
Molecular basis for anaphylaxis due to galactose-alpha-1,3-galactose (alpha-gal)R21AI154064 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2020 to 2021
$427k
Generation and characterization of full-length naturally occurring allergen-specific human IgE mAbsR21AI123307 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SCOTT ALAN · 2017 to 2018
$408k
BLRD VA I01 BX004299NCATS NIH HHS UL1 TR000445NIAID NIH HHS K08 AI103038NIAID NIH HHS R01 AI124456NIAID NIH HHS R01 AI130459NIAID NIH HHS R01 AI145265NIAID NIH HHS R01 AI155668NIAID NIH HHS R21 AI123307NIAID NIH HHS R21 AI145397NIAID NIH HHS R21 AI154064NIAID NIH HHS U19 AI095227
6 · The paper itself

Abstract

backgroundMuch of our understanding of the targets of IgE comes from studies of allergy, though little is known about the natural immunogenic targets seen after parasitic worm infections.

objectiveWe used human monoclonal antibodies (mAbs) for an unbiased and comprehensive characterization of the immunodominant antigens targeted by IgE in conditions like allergy or helminth infection that are associated with elevated levels of IgE.

methodsUsing human hybridoma technology to immortalize IgE encoding B-cells from peripheral blood of subjects with filarial infections and elevated IgE, we generated naturally occurring human IgE mAbs. B-cell cultures were screened in an unbiased manner for IgE production without regard to specificity. Isolated IgE mAbs were then tested for binding to Brugia malayi somatic extracts using ImmunoCAP, immunoblot, and ELISA. Immunoprecipitation followed by mass spectrometry proteomics was used to identify helminth antigens that were then expressed in Escherichia coli for IgE binding characterization.

resultsWe isolated 56 discrete IgE mAbs from 7 individuals with filarial infections. From these mAbs, we were able to definitively identify 19 filarial antigens. All IgE mAbs targeted filarial excreted/secretory proteins, including a family of previously uncharacterized proteins. Interestingly, the transthyretin-related antigens acted as the dominant inducer of the filaria-specific IgE antibody response. These filaria-specific IgE mAbs were potent inducers of anaphylaxis when passively administered to human FcεRI-expressing mice.

conclusionsWe generated human hybridomas secreting naturally occurring helminth-specific IgE mAbs from filarial-infected subjects. This work provides much-needed insight into the ontogeny of helminth-induced immune response and IgE antibody response.

Indexed as

HelminthsHypersensitivityAnimalsAntibodies, MonoclonalHumansMiceAntibodies, MonoclonalantibodieshelminthIgEmonoclonalparasite

Identifiers

PMID35760390
PMCPMC9742163
OpenAlexW4283464897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.